- Current status
- AHSCT is a standard of care of RRMS
- Wykłady na kursie specjalizacyjnym – transplantologia
- AHSCT is better choice than DMDs in MS as a treatment of cases progressing after first line treatment – multicenter randomised trial.
- CPX-351 (Vyxeos) – new drug that improves treatment in older patients with secondary AML
Monthly Archives: July 2015
JACIE is an international body that aims at improving standards connected to hematopoietic stem cell transplantation and distribution. You can read more about this organization at: http://www.jacie.org/. It seems that I am among the few polish physicians from polish transplant centers that got … Continue reading